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We estimated the influenza mortality burden in adults aged 60 years or older in the Netherlands in terms of years of life lost, taking into account competing mortality risks. Weekly laboratory surveillance data for influenza and other respiratory pathogens and weekly extreme temperature served as covariates in Poisson regression models fitted to weekly mortality data, specific to age group, for the period 1999-2000 through 2012-2013. Burden for age groups 60-64 years through 85-89 years was computed as years of life lost before age 90 (YLL90), using restricted mean lifetime survival analysis and accounting for competing risks. Influenza-attributable mortality burden was greatest for persons aged 80-84 years, at 914 YLL90 per 100,000 persons (95% uncertainty interval: 867, 963), followed by persons aged 85-89 years (787 YLL90/100,000; 95% uncertainty interval: 741, 834). Ignoring competing mortality risks in the computation of influenza-attributable YLL90 would lead to substantial overestimation of burden, from 3.5% for persons aged 60-64 years to 82% for those aged 80-89 years at death. Failure to account for competing mortality risks has implications for the accuracy of disease-burden estimates, especially among persons aged 80 years or older. Because the mortality burden borne by the elderly is notably high, prevention initiatives may benefit from being redesigned to more effectively prevent infection in the oldest age groups. competing risks; influenza; mortality; Netherlands; years of life lost Abbreviations: LE, life expectancy; YLL, years of life lost; YLL90, years of life lost before age 90.
Worldwide, infection with the influenza virus is responsible for considerable illness, hospitalization, and mortality, especially among older adults and elderly persons (1, 2) , whose immune response is diminished compared with younger adults (3, 4) . The mortality burden attributed to influenza virus infection is difficult to quantify from vital statistics data for several reasons: 1) death certificates often do not list influenza as an underlying or contributing cause when death is due to subsequent bacterial infection; 2) influenza infection may serve to worsen existing chronic respiratory or circulatory disease (5) so the chronic condition is entered as the underlying cause on the death certificate; and 3) laboratory confirmation of influenza infection is seldom done prior to death.
Given the public health significance of the large number of deaths presumed to be caused by influenza (e.g., influenza was estimated to have caused 11% of all deaths occurring in persons aged 65 years or older during the 2000-2009 influenza seasons in France (6)) but not registered as such (7), statistical modeling methods have been used to infer the true number of influenza-associated deaths from all-cause or cause-specific mortality data. Numerous studies have adopted an ecological approach to the estimation problem, by fitting generalized linear models that specify time-series of positive tests for influenza and other cocirculating respiratory pathogens from virological surveillance systems as covariates, possibly adjusting for systematic seasonal variation and other factors, to estimate the timeseries of influenza-attributable mortality (8) (9) (10) (11) (12) (13) (14) (15) (16) . Such methods exploit the seasonal patterns in pathogen activity, and are successful in that-given the modeling assumptions-the underestimation in influenza mortality burden when relying only on cause-of-death coding can be overcome.
Although mortality is an important epidemiologic indicator of the impact of an infectious disease in a population, the years of life lost (YLL) measure provides a more precise quantitative measurement than mortality incidence of the burden of influenza (and other diseases) among the elderly; with YLL, age at death (and so the expected remaining healthy life-years) is incorporated. The more prematurely death occurs, the higher the burden. Particularly for the elderly population, for whom the prevalence of chronic multimorbidity is high (17, 18) , it is vital to compute YLL for influenza, treating death from other causes as competing risks. The implicit assumption when calculating YLL associated with a single cause of death, such as influenza, is that removing this cause of death from the population would have no effect on the probability of dying from other causes. However, this independence assumption is in general not viable (19, 20) . To avoid overestimation of population-level total mortality burden, the YLL associated with each possible cause of death should sum exactly to the YLL calculated on the basis of all-cause mortality, and appropriate estimation methods are therefore required to ensure that cause-specific YLL correctly acknowledges competing mortality risks (21) (22) (23) . The relevance of this issue grows with the probability of death from other causes (i.e., with increasing age).
Thus, the principal objective of the current study was to estimate the weekly and annual mortality burden from influenza in adults 60 years of age or older in terms of YLL, taking into account competing mortality risks. Our secondary objective was to compare this measure with "standard" YLL, which ignores competing mortality risks.
METHODS

Study design and period
We considered the primary dependent variable for the modeling of influenza-attributable deaths to be mortality from any cause, but we additionally considered 2 other, more specific, cause-of-death categories: circulatory/respiratory causes and respiratory-only causes (11, 24) . The latter category was defined as underlying cause of death coded as J00-J99 (International Classification of Diseases, Tenth Revision) or 460-519 (International Classification of Diseases, Ninth Revision), and the former as these respiratory disease codes supplemented by the circulatory disease codes I00-I99 (International Classification of Diseases, Tenth Revision) or 390-459 (International Classification of Diseases, Ninth Revision).
The study period was defined as the 1999-2000 through 2012-2013 influenza seasons. Because death-certificate coding practice changed from the beginning of 2013, leading to notable changes in distribution over certain cause-of-death code categories, for the 2 more specific mortality outcomes the study period was defined to end one season earlier, at 2011-2012.
Data sources
All deaths in the Netherlands are registered with Statistics Netherlands. Weekly mortality data with primary cause-of-death information, stratified by 5-year age group (60-64 years through 80-84 years, as well as ≥85 years), were obtained for the period 1999-2013. Causes of death were coded using International Classification of Diseases, Tenth Revision. Because influenza circulates mainly during the winter months, seasons were defined as week 40 of a given year through week 39 of the following year.
Routine weekly surveillance data on positive laboratory results for a range of respiratory pathogens have been reported since 1989. Between 17 and 21 laboratories in the Netherlands submit weekly reports to a centralized database (the Weekly Sentinel Surveillance System of the Dutch Working Group on Clinical Virology (25) ). From these data, we counted polymerase chain reaction-confirmed positive samples for the following viral and bacterial agents: influenza A/B, respiratory syncytial virus, rhinovirus, parainfluenza, and Mycoplasma pneumoniae. We extracted data from 1999-2000 through 2012-2013, with seasons defined similarly as for mortality.
Poisson regression modeling of influenza-attributable mortality
In common with the general ecological modeling approach used in previous research (8-16), we assumed that seasonal variability in mortality can be explained, in part, by temporal variation in the reporting incidence of various respiratory pathogens. The proportion of mortality attributable to influenza can then be determined after adjusting for the cocirculation of other pathogens and other factors via linear regression techniques. We assumed additivity in this relationship for simplicity (i.e., a given death cannot be caused by more than 1 respiratory pathogen).
Separate Poisson regression models, with identity link function to enable an additive interpretation of model coefficients, were fitted to the weekly mortality data for each age group. Laboratory virological surveillance data were not available stratified by age; therefore each age-group regression model adjusted for the total positive samples reported for the pathogen.
Covariates. In addition to influenza A (coded using separate variables for each season, to capture seasonal variation in severity), the candidate pathogen covariates considered were influenza B, respiratory syncytial virus, rhinovirus, Mycoplasma pneumoniae, and parainfluenza.
Temperature is known to be an important correlate of mortality (26, 27) , although the relationship is not straightforward, given that it may be that only periods of extreme cold and heat influence the risk of death. We defined 2 covariates for temperature extremes, by first calculating the average weekly temperatures (T, in degrees Celsius) from daily temperatures recorded at the de Bilt (centrally located in the Netherlands) weather station and made available online by the Royal Netherlands Meteorological Institute (28) , and then coding extreme low temperature using the function max(0, 5 -T) and extreme high temperature as max(0, T -17) (10). This coding effectively treats temperatures as extreme if below 5°C or above 17°C.
Model selection. A defined model selection procedure was carried out separately for each age group. First, linear and quadratic terms were entered to model temporal trends in mortality (and so avoid overestimation of attribution to influenza or the other pathogens). We term this the base model.
We next considered the impact of 0-to 4-week lags between weekly surveillance reports of influenza A and B and other cocirculating pathogens and mortality (10) . Respiratory pathogens were explored one at a time using a forward selection procedure: Each lagged covariate was added independently to the base model, with the lag associated with the largest Akaike information criterion reduction selected. Next, to the base model now augmented with the selected lags for influenza A and B and the other respiratory pathogens, low and high extreme temperature terms were specified, and trigonometric terms were added to account for the assumed sinusoidal-shaped background mortality (modeling seasonal variation due to other causes). Next, pathogen covariates with negative coefficients were removed on grounds of biological implausibility (it is not plausible that pathogen infection would decrease the risk of death). Finally, the single influenza A term was replaced with 14 separate season-specific influenza coefficients; if any of these coefficients was negative, the model was refitted after removing these terms.
Models were therefore fitted of the form: We use the index i to refer to the week of the study period, the index j to refer to the pathogen, and the index s to refer to the season. Y is assumed to follow a Poisson distribution. Y i is the observed number of deaths in week i, β 0 is a constant (or intercept) term; the next terms capture linear and quadratic temporal trends with w i defined as the ith week in the study period. N is the total number of seasons for which season-specific influenza A coefficient α s is nonnegative, Z s,i are the weekly laboratoryreported, positive influenza A samples within season s, and X i,1...n are the weekly laboratory-reported, positive samples for up to n cocirculating pathogens (i.e., model fit-based selection from: influenza B, respiratory syncytial virus, rhinovirus, parainfluenza, and Mycoplasma pneumoniae), with potential lag of t j weeks. Additional included terms are for extreme temperature: T high,i and T low,i , and the two harmonic terms: sin (2πi/52.143) and cos(2πi/52.143).
The same procedure was applied to fit regression models to circulatory/respiratory and respiratory-only underlying cause mortality data. We constructed 95% prediction intervals around predicted weekly influenza-attributable deaths using bootstrapping methods.
Computation of YLL
YLL are standardly defined as the number of cause-specific deaths multiplied by the expected number of healthy life-years lost conditional on the age at death. This residual life expectancy (LE) is defined as how long a person would expect to live in an ideal world that is free of disease, assuming access to health care. For instance, the WHO Global Health Estimates projected LE values for 2050, citing a LE at birth of 92 years (29).
Andersen's (22) definition of YLL computed in a competing risk framework requires estimation of cause-specific cumulative risks of death, which in turn requires age-and/or time-specific cause-specific mortality data. Note that this approach differs from the "standard" YLL definition, in that the τ-restricted mean lifetime method from survival analysis is used instead of adopting age-specific LE from life tables. We defined τ = 90, so we effectively calculate YLL based on a LE of 90 years. We denote this variant of YLL as "YLL90," which can be interpreted as the expected number of life years lost before reaching the age of 90 years. To quantify the anticipated overestimation of mortality burden that would occur if competing mortality risks were ignored, we compare YLL90 with YLL computed based on Kaplan-Meier survival curves (see Web Appendix 1, available at https://academic.oup.com/aje).
The estimation of YLL90 was carried out using a simulation procedure applied to conditional survival functions defined for "cohorts" consisting of all persons within each age group at death (see Web Appendix 1 for a detailed description). Cumulative mortality incidence curves were then constructed for influenza-attributable deaths and all other causes of death, and YLL90 for each cause category was calculated accordingly (Web Appendix 1; see also Refs. (22, 23) ). This simulation procedure was repeated 1,000 times, with the uncertainty inherent in the resulting distributions of influenza-attributable YLL90 according to age group, combined with the 95% prediction intervals for predicted influenza-attributable deaths, yielding 95% uncertainty intervals for YLL90.
Within each iteration, YLL90 was calculated for each age group and season, simulating conditional survival functions based on the weekly predicted number of influenza-attributable deaths derived from the corresponding fitted Poisson models and the national population estimates (see Web Appendix 1 for further details).
Outcomes and statistical analysis
We present the weekly and annual YLL90 due to influenzaattributable mortality both in absolute terms and also as the proportion of annual total YLL90 within the entire outcome category (all-cause, circulatory/respiratory, or respiratory only), thus considering deaths from causes other than influenza as competing risks. The latter measure-proportion of total YLL90-permits declining secular trends in mortality to be taken into account. In addition, to allow comparisons of mortality burden between age groups, we report YLL90 per 100,000 persons. This measure controls for differences in age-group population size (and thus adjusts for demographic change; i.e., the growing and aging Dutch population (30)) so that influenza mortality burden can be meaningfully compared across age groups. Finally, interseasonal variability was quantified as the standard deviation of the YLL90-per-100,000 measure.
All modeling was conducted using R, version 3.2.0 (R Foundation for Statistical Computing, Vienna, Austria) (31) .
RESULTS
The total number of influenza-attributable deaths in persons aged ≥60 years ranged from 40 to 3,330 over the seasons (1.3% of all deaths) and varied according to age group, with the highest influenza mortality rate estimated for those aged ≥85 years (see Web Table1 and Web Figure 1 ). Models fitted to more specific cause-of-death data (i.e., respiratory/circulatory underlying causes and respiratory causes only) showed similar temporal patterns but with smaller absolute numbers (Web Figures 2 and 3) .
Influenza-attributable mortality burden exhibited considerable seasonal variability, with YLL90 ranging from 480 to 30,680 across seasons within the study period ( Table 1) . The age group 85-89 years, although contributing the largest estimated number of influenza-associated deaths (1.7% of the cumulative total registered deaths in this age group over the study period), did not incur the largest absolute influenza-attributable burden; this was observed for the age group 80-84 years, with across-season average YLL90 of 2,992 ( Table 2) .
Between 0.04% and 2.37% of the total YLL90 per season in persons aged 60-89 years was attributed to influenza (Table 1 and Figure 1 ). This proportion measure, which adjusts for any secular changes in overall mortality risk, tended to decrease over the study period. The age group 85-89 years was responsible for the largest share of the total mortality burden specific to age group (1.61%) ( Table 2) .
Estimates using more specific cause-of-death data-respiratory/circulatory underlying causes and respiratory causes onlywere comparable to the all-cause results, in showing similar decreasing temporal trends in the proportion of total YLL90 attributed to influenza (Web Figures 4 and 5) , and rankings according to age group of this proportion measure were similar. However, lower absolute YLL90 and YLL90-per-100,000 rates (Web Tables 2 and 3) were obtained, due to smaller numbers of influenza-attributed deaths. Influenza-attributable YLL90 per 100,000 persons for allcause mortality is depicted in Web Figure 6 . The YLL90 rates for the younger age groups (i.e., 60-64 years, 65-69 years) varied widely across the seasons of the study period, but variation in the burden was even more pronounced for persons aged 80-89 years ( Figure 2 and Table 1 ). A similar age pattern was observed if YLL90 was calculated using more specific cause-of-death data (Web Figures 7 and 8) . When standardizing for age-group population size and aggregating over seasons, the highest burden (YLL90 of 914/100,000; 95% uncertainty interval: 867, 963) was observed for the age group 80-84 years, with the second (Table 2 ). YLL90 for these 2 age groups is notably high; YLL90 for the age group with next highest burden, 75-79 years, was 37% lower, at 575/100,000 (95% uncertainty interval: 540, 613).
Ignoring competing mortality risks tended to overestimate the overall mortality burden. For persons aged 60-64 years at death, YLL computed based on Kaplan-Meier survival curves yielded an overall 3.5% higher total mortality burden attributed to influenza compared with YLL90 (Table 2) . However, the extent of overestimation increased with age; for persons aged 80-89 years, overestimation was 82%.
DISCUSSION
In terms of the estimated number of influenza-attributable deaths, the highest burden was observed for persons aged 85 years or older. However, the YLL90 measure provides an alternative view of mortality burden by taking into account age at death and competing risks of death from other causes. Of the total YLL90 calculated from all-cause mortality, the greatest proportion attributable to influenza (1.61%) was also among persons aged 85-89 years. The next youngest age groups (80-84 years and 75-79 years) had the second and third largest influenza-attributable shares of the mortality burden. However, the age-standardized mortality burden measure YLL90 per 100,000 persons localized the highest mortality burden to the age group 80-84 years, followed by those aged 85-89 years.
Our estimates of the proportion of total YLL90 per season in persons aged 60-89 years that is due to influenza, although small on average (ranging from 0.04% to 2.37% across seasons; Table 1 ), are also lower than if YLL is computed ignoring competing mortality risks. Burden according to age group varied between the 2 measures; for persons aged 80-89 years, the latter YLL measure yielded a notably higher (82%) estimated mortality burden. This suggests that competing risks for mortality in the elderly should be considered when estimating influenza mortality burden using statistical modeling approaches.
The age group-specific influenza-attributable proportion ranged from an across-season average of 0.67% for 60-64 year-olds to an average of 1.61% for 85-89 year-olds (Table 2) . However, averaging influenza-attributable mortality burden obscures variation over time. There was also substantial variation in YLL90 per 100,000 according to age group, particularly for persons aged 80 years or older (Figure 2 ), which suggests that variation in seasonal severity (32) may disproportionately affect the most aged segment of the population. This variation reflects a complex interplay between the circulating virus strain distribution, vaccine mismatch, and degree of natural immunity (33) .
The temporal patterns and magnitude of influenza-attributable mortality we obtained were comparable to previous statistical modeling exercises conducted using Netherlands data for wider age groups. Van Asten et al. (10) estimated that 1.5% of total deaths among those aged ≥65 years in the period 1999-2007 were due to influenza A; we observed 1.4% of total deaths to be due to influenza A/B for the same age group in the longer period which is necessarily lower due to the incorporation of competing mortality risks in the YLL90 calculation. We used all-cause mortality in the main analysis. Because influenza infection plays a larger role for certain causes of death, one can also estimate burden based on more specific cause-of-death categories. Supplementary analyses using circulatory/respiratory and respiratory-only mortality data were largely consistent with the results based on all-cause mortality. Although the estimated influenza-attributable YLL90 and YLL90 per 100,000 were lower, the greater mortality burden for persons aged 80-89 years was replicated.
Attribution of influenza-caused mortality via Poisson regression is technically challenging (36) and is consequently subject to several limitations. First, through inclusion of harmonic terms to capture seasonal patterns in mortality unaccounted for by the included covariates, we effectively made the assumption that the impact of these unmeasured influences is static across seasons. This could lead to over-or underestimation of the associations between the activity of other pathogens and mortality in a given season; alternative regression modeling techniques (37) may improve model fit. Related to this issue, by fitting a single, time-invariant regression coefficient for each circulating pathogen other than influenza A, the number of weekly deaths attributable to these pathogens was constrained to be a constant proportion of the reported positive tests. Finally, we assumed that there were no historical changes in testing/reporting that would affect the laboratory surveillance data.
Because age at death was available only at a granularity of 5 years, our method randomly allocated an age at death for the calculation of cumulative mortality incidence and YLL90. This led to lower precision in age-specific YLL90 than if the exact age at death had been known. The restricted mean lifetime approach requires definition of a maximum attainable age. Using a higher limit (e.g., 95 years) would inflate the estimated absolute YLL90 and YLL90/100,000 values, but age groupspecific proportions would not change appreciably.
Our quantitative estimation of the mortality burden due to influenza in the Netherlands over a 14-season analysis period indicates that the greatest burden, adjusting for population size, is borne by persons aged 80 years or older, and is highest for the age group 80-84 years. The more aged segment of persons targeted by the Dutch national influenza prevention program has a historically higher vaccination uptake (≥75 years: 85% in 2008) than younger eligible persons (65-74 years: 73% in 2008) (38) , but uptake does not translate directly into protection. Although the single, large randomized trial conducted to date yielded a vaccine efficacy of 59% (95% confidence interval: 20, 79) for the youngest (aged 60-69 years) decade of our study population (39) , evidence regarding vaccine efficacy of the (inactivated) flu vaccine for persons aged 70 years or older is lacking.
Because the Dutch residual life expectancy upon reaching one's 80th birthday is about 9 years, substantial mortality burden could be averted by preventing influenza in the elderly. Given the large observed degree of interseasonal variability in mortality burden borne by the oldest age groups-related to the strain distribution, vaccine mismatch (40) , virus pathogenicity, vaccination coverage, and drivers of transmission-the most vulnerable elderly may benefit from being targeted for further prevention measures as supplement to routine flu vaccination.
